SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001104659-18-008958
Filing Date
2018-02-13
Accepted
2018-02-13 15:08:23
Documents
1
Group Members
VERSANT VENTURE CAPITAL IV, L.P.VERSANT VENTURES IV, LLC

Document Format Files

Seq Description Document Type Size
1 SC 13G/A a18-5924_1sc13ga.htm SC 13G/A 130712
  Complete submission text file 0001104659-18-008958.txt   132342
Mailing Address ONE SANSOME STREET SUITE 3630 SAN FRANCISCO CA 94104
Business Address ONE SANSOME STREET SUITE 3630 SAN FRANCISCO CA 94104 650-233-2211
Versant Side Fund IV, L.P. (Filed by) CIK: 0001456591 (see all company filings)

IRS No.: 263614950 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 600 CALIFORNIA ST., 17TH FLOOR SAN FRANCISCO CA 94108
Business Address 600 CALIFORNIA ST., 17TH FLOOR SAN FRANCISCO CA 94108 415-638-6556
Audentes Therapeutics, Inc. (Subject) CIK: 0001628738 (see all company filings)

IRS No.: 461606174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-89574 | Film No.: 18602636
SIC: 2836 Biological Products, (No Diagnostic Substances)